Biostar Pharmaceuticals, Inc.
BSPM
BSPM was delisted on the 18th of September, 2018.
8 hedge funds and large institutions have $324K invested in Biostar Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
33% more funds holding
Funds holding: 6 → 8 (+2)
36% less capital invested
Capital invested by funds: $506K → $324K (-$182K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$32K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$11.7K |
| 3 |
Renaissance Technologies
New York
|
+$7.28K |
| 4 |
Morgan Stanley
New York
|
+$17 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$380 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $284K | +$7.28K | +1,686 | +2% |
|
|
2
Citadel Advisors
Miami,
Florida
| $21K | +$32K | +7,412 | New |
|
|
VKH
3
Virtu KCG Holdings
New York
| $8K | +$11.7K | +2,707 | New |
|
4
California Public Employees Retirement System
Sacramento,
California
| $6K | – | – | – |
|
|
ISB
5
Iowa State Bank
Urbandale,
Iowa
| $5K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$380 | -88 | -84% |
|
|
7
Morgan Stanley
New York
| – | +$17 | +4 | +17% |
|
BSPM Hedge Fund Activity: Q4 2015 in Review
8 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Biostar Pharmaceuticals, Inc. (BSPM) for Q4 2015, worth a combined $324K — down 36% from $506K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BSPM positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $32K. The largest seller was UBS Group, cutting an estimated $380.
- 8 institutional investors held Biostar Pharmaceuticals, Inc. (BSPM) as of Q4 2015, up from 6 in Q3 2015.
- Funds reported $324K of Biostar Pharmaceuticals, Inc. stock for Q4 2015, down 36% quarter-over-quarter.
- 2 funds opened new Biostar Pharmaceuticals, Inc. positions in Q4 2015 and 0 closed out, a net change of +2 holders.
- The largest Biostar Pharmaceuticals, Inc. buyer in Q4 2015 was Citadel Advisors, an estimated $32K added.
- The largest Biostar Pharmaceuticals, Inc. seller in Q4 2015 was UBS Group, an estimated $380 sold.
Based on aggregated 13F filings for Q4 2015.